What is Regional Health Pptys Inc's earnings per share (EPS)?

Regional Health Pptys Inc (RHEPB) reported diluted earnings per share of $1.09 for fiscal year 2025. This represents a 163.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Regional Health Pptys Inc Financials

RHEPB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Regional Health Pptys Inc (RHEPB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RHEPB FY2025 2026-04-22

FY2025's accounting profit rested on cash inflows outside operations, while the day-to-day business still carried thin margins and strained liquidity.

Between FY2024 and FY2025, net income flipped positive to $3.4M even as operating cash flow fell to -$2.3M. Cash still increased because investing cash flow brought in $15.1M while financing used -$10.3M, so the year looked stronger on earnings than on self-funding capacity from the business itself.

Core profitability remained narrow: FY2025 operating income was only $1.7M on revenue of $53.2M, leaving little cushion before debt service or any working-capital strain. Because interest expense exceeded operating income at $2.7M, reported profit likely depended on gains below the operating line rather than on recurring operations alone.

Balance-sheet repair is visible in the debt load, with long-term debt falling from $50.7M in FY2023 to $34.7M in FY2025. Even after that, the company ended with only $349K of equity and a current ratio of 0.7x, so leverage looks lower in dollars than it does in actual balance-sheet resilience.

Financial Health Signals

Financial Profile 44/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Regional Health Pptys Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Regional Health Pptys Inc has an operating margin of 3.1%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 24/100, suggesting thin profitability after operating expenses. This is up from 0.9% the prior year.

Growth

100

Regional Health Pptys Inc's revenue surged 189.9% year-over-year to $53.2M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Regional Health Pptys Inc has elevated debt relative to equity (D/E of 99.54), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Regional Health Pptys Inc's current ratio of 0.67 is below the typical benchmark, resulting in a score of 8/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Regional Health Pptys Inc generated -$2.3M in operating cash flow, capex of $869K consumed most of it, leaving -$3.1M in free cash flow. This results in a low score of 31/100, reflecting heavy capital investment rather than weak cash generation.

Returns

100

Regional Health Pptys Inc earns a strong 965.6% return on equity (ROE), meaning it generates $966 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.

Piotroski F-Score Neutral

5/9

Regional Health Pptys Inc passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

-0.67x

For every $1 of reported earnings, Regional Health Pptys Inc generates $-0.67 in operating cash flow (-$2.3M OCF vs $3.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

0.6x

Regional Health Pptys Inc earns $0.6 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$53.2M

YoY+189.9%

5Y CAGR+24.8%

10Y CAGR+11.2%

Regional Health Pptys Inc generated $53.2M in revenue in fiscal year 2025. This represents an increase of 189.9% from the prior year.

EBITDA

$3.7M

YoY+67.7%

5Y CAGR-6.4%

Regional Health Pptys Inc's EBITDA was $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.7% from the prior year.

Net Income

$3.4M

YoY+204.7%

Regional Health Pptys Inc reported $3.4M in net income in fiscal year 2025. This represents an increase of 204.7% from the prior year.

EPS (Diluted)

$1.09

YoY+163.0%

Regional Health Pptys Inc earned $1.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 163.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$3.1M

YoY-321.4%

Regional Health Pptys Inc generated -$3.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 321.4% from the prior year.

Cash & Debt

$3.0M

YoY+415.5%

5Y CAGR-6.5%

10Y CAGR+1.0%

Regional Health Pptys Inc held $3.0M in cash against $34.7M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+109.4%

5Y CAGR+18.4%

Regional Health Pptys Inc had 4M shares outstanding in fiscal year 2025. This represents an increase of 109.4% from the prior year.

Margins & Returns

Gross Margin

86.9%

Regional Health Pptys Inc's gross margin was 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

3.1%

YoY+2.3pp

5Y CAGR-9.9pp

10Y CAGR+44.7pp

Regional Health Pptys Inc's operating margin was 3.1% in fiscal year 2025, reflecting core business profitability. This is up 2.3 percentage points from the prior year.

Net Margin

6.3%

YoY+23.9pp

5Y CAGR+10.3pp

10Y CAGR+134.2pp

Regional Health Pptys Inc's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 23.9 percentage points from the prior year.

Return on Equity

965.6%

5Y CAGR+971.8pp

Regional Health Pptys Inc's ROE was 965.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$869K

YoY+64.0%

5Y CAGR+14.1%

10Y CAGR-7.0%

Regional Health Pptys Inc invested $869K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 64.0% from the prior year.

RHEPB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$53.2M+189.9%	$18.3M+6.8%	$17.2M-52.2%	$35.9M+34.6%	$26.7M+51.8%	$17.6M
Cost of Revenue	$7.0M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$46.2M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$12.0M+122.7%	$5.4M-0.1%	$5.4M+16.3%	$4.7M+18.3%	$3.9M+16.5%	$3.4M
Operating Income	$1.7M+933.5%	$161K+119.6%	-$821K+88.0%	-$6.8M-369.3%	$2.5M+10.4%	$2.3M
Interest Expense	$2.7M-1.4%	$2.7M-1.5%	$2.8M+8.8%	$2.5M-5.2%	$2.7M-3.9%	$2.8M
Income Tax	$108K	N/A	N/A	N/A	N/A	N/A
Net Income	$3.4M+204.7%	-$3.2M+17.2%	-$3.9M+43.4%	-$6.9M-481.0%	-$1.2M-71.8%	-$688K
EPS (Diluted)	$1.09+163.0%	$-1.73-108.2%	$21.05+335.7%	$-8.93-52.1%	$-5.87	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$20.8M+37.2%	$15.1M+50.5%	$10.1M+39.9%	$7.2M+27.1%	$5.7M+33.9%	$4.2M-2.3%	$4.3M+4.8%	$4.1M
Cost of Revenue	N/A	$2.5M	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$12.7M	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$3.7M-1.2%	$3.7M+52.9%	$2.4M+8.9%	$2.2M+68.6%	$1.3M+8.1%	$1.2M-0.4%	$1.2M-24.7%	$1.6M
Operating Income	$3.1M+619.2%	-$594K-16.9%	-$508K-59.7%	-$318K-158.8%	$541K+280.3%	-$300K-240.2%	$214K+172.8%	-$294K
Interest Expense	$652K-13.2%	$751K+22.1%	$615K-5.8%	$653K-5.4%	$690K+1.9%	$677K+1.2%	$669K-0.7%	$674K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$2.7M-20.2%	$3.4M+333.4%	-$1.4M-14.8%	-$1.3M-122.2%	-$568K+42.2%	-$982K-39.1%	-$706K+26.6%	-$962K
EPS (Diluted)	N/A	$1.17+272.1%	$-0.68+27.7%	$-0.94	N/A	$-0.52-36.8%	$-0.38+26.9%	$-0.52

RHEPB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$67.8M+12.1%	$60.5M-2.8%	$62.2M-9.3%	$68.6M-35.1%	$105.7M-2.2%	$108.0M
Current Assets	$16.3M+138.8%	$6.8M	N/A	N/A	N/A	N/A
Cash & Equivalents	$3.0M+415.5%	$582K-41.8%	$1.0M+25.0%	$800K-88.2%	$6.8M+61.9%	$4.2M
Inventory	$1.4M	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$8.0M+138.7%	$3.4M+140.1%	$1.4M-77.7%	$6.3M+193.2%	$2.1M+2.1%	$2.1M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$62.8M-1.0%	$63.4M+2.2%	$62.0M-4.4%	$64.9M-31.9%	$95.3M-1.7%	$96.9M
Current Liabilities	$24.2M+18.4%	$20.4M	N/A	N/A	N/A	N/A
Long-Term Debt	$34.7M-11.6%	$39.3M-22.6%	$50.7M-2.8%	$52.2M-1.3%	$52.9M-2.9%	$54.4M
Total Equity	$349K+112.0%	-$2.9M-1677.8%	$185K-95.0%	$3.7M-64.3%	$10.4M-6.4%	$11.1M
Retained Earnings	-$81.8M+3.9%	-$85.1M-3.9%	-$81.9M+32.5%	-$121.4M-6.0%	-$114.5M-1.0%	-$113.4M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$67.8M-6.0%	$72.2M+20.0%	$60.1M+1.4%	$59.3M-2.0%	$60.5M+0.7%	$60.1M-2.1%	$61.3M+0.2%	$61.2M
Current Assets	$16.3M	N/A	N/A	N/A	$6.8M	N/A	N/A	N/A
Cash & Equivalents	$3.0M+200.0%	$1.0M+150.0%	$400K-20.0%	$500K-14.1%	$582K+16.4%	$500K-28.6%	$700K-12.5%	$800K
Inventory	$1.4M-5.6%	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$8.0M+4.0%	$7.7M+76.7%	$4.4M+20.0%	$3.6M+8.3%	$3.4M+65.3%	$2.0M+11.9%	$1.8M+24.1%	$1.5M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$62.8M-9.0%	$69.0M+5.2%	$65.6M+3.4%	$63.4M+0.1%	$63.4M+1.5%	$62.4M-0.5%	$62.7M+1.3%	$62.0M
Current Liabilities	$24.2M	N/A	N/A	N/A	$20.4M	N/A	N/A	N/A
Long-Term Debt	$34.7M-28.5%	$48.6M-0.7%	$48.9M-0.5%	$49.2M+25.1%	$39.3M-20.9%	$49.7M-1.2%	$50.2M+0.5%	$50.0M
Total Equity	$349K+122.7%	-$1.5M+71.8%	-$5.5M-31.1%	-$4.2M-42.5%	-$2.9M-22.6%	-$2.4M-68.0%	-$1.4M-93.1%	-$734K
Retained Earnings	-$81.8M+3.5%	-$84.8M+4.1%	-$88.4M-1.7%	-$87.0M-2.2%	-$85.1M-0.7%	-$84.6M-1.2%	-$83.6M-0.9%	-$82.9M

RHEPB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$2.3M-216.3%	$1.9M-47.7%	$3.7M+203.2%	-$3.6M-173.5%	$4.9M+277.9%	$1.3M
Capital Expenditures	$869K+64.0%	$530K-44.7%	$958K+240.9%	$281K+128.5%	$123K-72.7%	$450K
Free Cash Flow	-$3.1M-321.4%	$1.4M-48.7%	$2.8M+171.0%	-$3.9M-181.3%	$4.8M+464.6%	$845K
Investing Cash Flow	$15.1M+2949.4%	-$530K+44.7%	-$958K-240.9%	-$281K-128.5%	-$123K+72.7%	-$450K
Financing Cash Flow	-$10.3M-382.4%	-$2.1M+14.3%	-$2.5M-20.2%	-$2.1M+14.6%	-$2.4M-73.6%	-$1.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	$46K+557.1%	$7K	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$1.3M+29.6%	-$1.8M-416.2%	$569K+141.1%	$236K-75.2%	$953K+950.9%	-$112K-122.2%	$505K-15.4%	$597K
Capital Expenditures	$226K-20.1%	$283K-4.1%	$295K+353.8%	$65K-35.0%	$100K+185.7%	$35K-89.7%	$340K+518.2%	$55K
Free Cash Flow	-$1.5M+28.3%	-$2.1M-859.9%	$274K+60.2%	$171K-80.0%	$853K+680.3%	-$147K-189.1%	$165K-69.6%	$542K
Investing Cash Flow	$9.8M+71.6%	$5.7M+2029.5%	-$295K-353.8%	-$65K+35.0%	-$100K-185.7%	-$35K+89.7%	-$340K-518.2%	-$55K
Financing Cash Flow	-$6.4M-106.8%	-$3.1M-2470.2%	-$121K+79.4%	-$587K+33.5%	-$883K-1277.3%	$75K+113.3%	-$566K+24.6%	-$751K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RHEPB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	86.9%	N/A	N/A	N/A	N/A	N/A
Operating Margin	3.1%+2.3pp	0.9%+5.7pp	-4.8%+14.2pp	-19.0%-28.5pp	9.5%-3.6pp	13.1%
Net Margin	6.3%+23.9pp	-17.5%+5.1pp	-22.7%-3.5pp	-19.1%-14.7pp	-4.4%-0.5pp	-3.9%
Return on Equity	965.6%	N/A	-2101.6%-1916.8pp	-184.8%-173.4pp	-11.4%-5.2pp	-6.2%
Return on Assets	5.0%+10.3pp	-5.3%+0.9pp	-6.3%+3.8pp	-10.0%-8.9pp	-1.1%-0.5pp	-0.6%
Current Ratio	0.67+0.3	0.33	N/A	N/A	N/A	N/A
Debt-to-Equity	99.54+113.0	-13.46-287.7	274.24+260.2	14.04+9.0	5.09+0.2	4.90
FCF Margin	-5.9%-13.6pp	7.7%-8.3pp	16.1%+26.8pp	-10.8%-28.7pp	17.9%+13.1pp	4.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	83.7%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	14.8%+18.8pp	-3.9%+1.1pp	-5.1%-0.6pp	-4.4%-14.0pp	9.6%+16.7pp	-7.1%-12.0pp	5.0%+12.1pp	-7.1%
Net Margin	13.0%-9.3pp	22.3%+36.8pp	-14.4%+3.1pp	-17.5%-7.5pp	-10.0%+13.2pp	-23.2%-6.9pp	-16.3%+7.0pp	-23.3%
Return on Equity	773.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	4.0%-0.7pp	4.7%+7.1pp	-2.4%-0.3pp	-2.1%-1.2pp	-0.9%+0.7pp	-1.6%-0.5pp	-1.1%+0.4pp	-1.6%
Current Ratio	0.67	N/A	N/A	N/A	0.33	N/A	N/A	N/A
Debt-to-Equity	99.54+131.1	-31.59-22.6	-8.97+2.9	-11.82+1.6	-13.46+7.4	-20.86+14.6	-35.46+32.7	-68.13
FCF Margin	-7.2%+6.6pp	-13.8%-16.5pp	2.7%+0.3pp	2.4%-12.7pp	15.1%+18.6pp	-3.5%-7.3pp	3.8%-9.3pp	13.1%

Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Selectis Health Inc GBCS

$13.8M

Ethema Hlth GRST

$773K

Cardiff Lexingto CDIX

$28.3M

Numinus Wellness Inc. NUMIF

$16.0M

Biocorrx Inc BICX

$10.6M

Frequently Asked Questions

What is Regional Health Pptys Inc's annual revenue?

Regional Health Pptys Inc (RHEPB) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Regional Health Pptys Inc's revenue growing?

Regional Health Pptys Inc (RHEPB) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.

Is Regional Health Pptys Inc profitable?

Yes, Regional Health Pptys Inc (RHEPB) reported a net income of $3.4M in fiscal year 2025, with a net profit margin of 6.3%.

What is Regional Health Pptys Inc's EBITDA?

Regional Health Pptys Inc (RHEPB) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Regional Health Pptys Inc have?

As of fiscal year 2025, Regional Health Pptys Inc (RHEPB) had $3.0M in cash and equivalents against $34.7M in long-term debt.

What is Regional Health Pptys Inc's gross margin?

Regional Health Pptys Inc (RHEPB) had a gross margin of 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Regional Health Pptys Inc's operating margin?

Regional Health Pptys Inc (RHEPB) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Regional Health Pptys Inc's net profit margin?

Regional Health Pptys Inc (RHEPB) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Regional Health Pptys Inc's return on equity (ROE)?

Regional Health Pptys Inc (RHEPB) has a return on equity of 965.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Regional Health Pptys Inc's free cash flow?

Regional Health Pptys Inc (RHEPB) generated -$3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Regional Health Pptys Inc's operating cash flow?

Regional Health Pptys Inc (RHEPB) generated -$2.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Regional Health Pptys Inc's total assets?

Regional Health Pptys Inc (RHEPB) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Regional Health Pptys Inc's capital expenditures?

Regional Health Pptys Inc (RHEPB) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Regional Health Pptys Inc have outstanding?

Regional Health Pptys Inc (RHEPB) had 4M shares outstanding as of fiscal year 2025.

What is Regional Health Pptys Inc's current ratio?

Regional Health Pptys Inc (RHEPB) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Regional Health Pptys Inc's debt-to-equity ratio?

Regional Health Pptys Inc (RHEPB) had a debt-to-equity ratio of 99.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Regional Health Pptys Inc's return on assets (ROA)?

Regional Health Pptys Inc (RHEPB) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Regional Health Pptys Inc's cash runway?

Based on fiscal year 2025 data, Regional Health Pptys Inc (RHEPB) had $3.0M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Regional Health Pptys Inc's Piotroski F-Score?

Regional Health Pptys Inc (RHEPB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Regional Health Pptys Inc's earnings high quality?

Regional Health Pptys Inc (RHEPB) has an earnings quality ratio of -0.67x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Regional Health Pptys Inc cover its interest payments?

Regional Health Pptys Inc (RHEPB) has an interest coverage ratio of 0.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Regional Health Pptys Inc?

Regional Health Pptys Inc (RHEPB) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.